Clinical Trial: Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07094763) titled 'Efficacy and Safety of Tenecteplase Intravenous Thrombolysis in Acute Posterior Circulation Ischemic Stroke Within 4.5-24 Hours After Onset' on July 23.

Brief Summary: This study aims to evaluate the efficacy and safety of tenecteplase (TNK) intravenous thrombolysis within the extended time window (4.5 to 24 hours) in patients with acute posterior circulation ischemic stroke.

Study Start Date: Aug. 05

Study Type: INTERVENTIONAL

Condition: Acute Ischemic Stroke

Intervention: DRUG: TNK plus standard medical treatment

Patients in the TNK treatment group will receive TNK intravenous thrombolysis and the usual dosage for TNK intra...